SCHEMBL3772672

SCHEMBL3772672

COc1ccc2cc(S(=O)(=O)O)ccc2c1.[NaH]

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
L3MBTL1 Q9Y468 2/20 0.58
KDM4E B2RXH2 4/20 0.56
TSHR P16473 2/20 0.56
CASP1 P29466 1/20 0.55
HSD17B10 Q99714 1/20 0.55
PLAU P00749 4/20 0.53
SNCA P37840 2/20 0.50
LMNA P02545 1/20 0.50
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
PTGS2 P35354 1/20 0.49
CYP1A2 P05177 1/20 0.48
CYP2A6 P11509 1/20 0.48
PKM P14618 1/20 0.48
RAPGEF3 O95398 1/20 0.48
SLC2A1 P11166 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1726389 0.98 MEN1 (0.61) MEN1KMT2AL3MBTL1KDM4ETSHR
SCHEMBL4016088 0.96 MEN1 (0.59) MEN1KMT2AL3MBTL1KDM4ETSHR
SCHEMBL2326546 0.95 MEN1 (0.58) MEN1KMT2AL3MBTL1KDM4ETSHR
Hydrochloric Acid SCHEMBL27504393 0.93 MEN1 (0.56) MEN1KMT2AL3MBTL1KDM4ETSHR
SCHEMBL3101290 0.84 SNCA (0.60) KDM4ETSHRHSD17B10SNCALMNA
SCHEMBL836622 0.84 SNCA (0.60) KDM4ETSHRHSD17B10SNCALMNA
SCHEMBL4016326 0.84 SNCA (0.49) MEN1KMT2AL3MBTL1KDM4ETSHR
SCHEMBL5352921 0.82 SNCA (0.51) MEN1KMT2AL3MBTL1KDM4ETSHR
SCHEMBL10497952 0.82 PKM (0.64) L3MBTL1KDM4ELMNAHTTPTGS2
SCHEMBL300937 0.82 SNCA (0.62) KDM4ETSHRHSD17B10SNCALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435978-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2013-05-07 US disclosed
US-20100324009-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-12-23 US disclosed
US-20100317644-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-12-16 US disclosed
EP-1085540-B1 SOLID ELECTROLYTIC CAPACITOR AND METHOD FOR PREPARING THE SAME SHOWA DENKO KK (JP) 2009-07-01 EP disclosed
EP-1158551-B1 SOLID ELECTROLYTIC CAPACITOR AND ITS PRODUCTION METHOD SHOWA DENKO KK (JP) 2008-11-19 EP disclosed
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS GRUENENTHAL GMBH (DE) 2008-06-26 US disclosed
EP-1811532-A2 Solid electrolytic capacitor and method for producing the same SHOWA DENKO KABUSHIKI KAISHA (JP) 2007-07-25 EP disclosed
EP-1190426-B1 SOLID ELECTROLYTIC CAPACITOR AND METHOD FOR PRODUCING THE SAME SHOWA DENKO KK (JP) 2007-05-30 EP disclosed
US-20060217362-A1 Novel compounds useful for bradykinin B1 receptor antagonism ELAN PHARMACEUTICALS, INC. 2006-09-28 US disclosed
US-20060179627-A1 Valve acting metal having pores, dielectric film formed on surface, and electroconductive polythiophene as solid electrolyte provided on dielectric film; improved moisture/heat/thermal stess resistance SHOWA DENKO K.K. 2006-08-17 US disclosed
US-20030148023-A1 Solid electrolytic capacitor and method for producing the same SHOWA DENKO K.K. 2003-08-07 US disclosed
US-6517892-B1 Forming electroconductive film filling microfine pores and covering dielectric layer; oxidative solution polymerization; such as cationic polythiophene or polyfuran SHOWA DENKO K.K. (JP) 2003-02-11 US disclosed
US-6466421-B1 Solid electrolytic capacitor and method for producing the same SHOWA DENKO K.K. (JP) 2002-10-15 US disclosed
US-20020105777-A1 Solid electrolytic capacitor and method for producing the same SHOWA DENKO K.K. 2002-08-08 US disclosed
US-6381121-B1 Solid electrolytic capacitor SHOWA DENKO KABUSHIKI KAISHA (JP) 2002-04-30 US disclosed
EP-1190426-A1 SOLID ELECTROLYTIC CAPACITOR AND METHOD FOR PRODUCING THE SAME Showa Denko K K (JP) 2002-03-27 EP disclosed
US-6344966-B1 ELECTRICALLY CONDUCTING POLYMER LAYER CONTAINS AS A DOPANT AN ANION OF(1) ALKOXY-SUBSTITUTED NAPHTHALENESULFONATE, (2) A HETEROCYCLIC SULFONATE, OR (3) AN ANION OF AN ALIPHATIC POLYCYCLIC COMPOUND SHOWA DENKO K.K. (JP) 2002-02-05 US disclosed
EP-1158551-A1 SOLID ELECTROLYTIC CAPACITOR AND ITS PRODUCTION METHOD Showa Denko K K (JP) 2001-11-28 EP disclosed
EP-1085540-A1 SOLID ELECTROLYTIC CAPACITOR AND METHOD FOR PREPARING THE SAME Showa Denko K K (JP) 2001-03-21 EP disclosed
WO-2000060620-A1 SOLID ELECTROLYTIC CAPACITOR AND METHOD FOR PRODUCING THE SAME SHOWA DENKO K. K. (JP) 2000-10-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317644-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 MEN1 4354/4885KMT2A 1686/4885L3MBTL1 4648/4885
US-20100324009-A1 Substituted Sulfonamide Compounds SULT2A1, STS, SULT1A1 MEN1 4354/4885KMT2A 1686/4885L3MBTL1 4648/4885
US-20080153843-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS SULT2A1, STS, SULT1A1 MEN1 4354/4885KMT2A 1686/4885L3MBTL1 4648/4885
US-20060217362-A1 Novel compounds useful for bradykinin B1 receptor antagonism BDKRB1, BDKRB2, NPBWR1 MEN1 998/4885KMT2A 4104/4885L3MBTL1 661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.